Analysis: Lyka Labs Limited

NSE:LYKALABS Pharma - Formulators Market cap: ₹264 cr

Research report

companyname: Lyka Labs Limited ticker: LYKALABS sector: Pharmaceuticals – formulations manufacturing (sterile injectables, topicals, lyophilised products) Lyka Labs is a pharmaceutical formulations manufacturer that has been operating since 1976. It makes four product forms - dry powder injections, liquid injections, lyophilised (freeze-dried) injections, and external preparations like ointments, creams and lotions - for both international markets and the Indian domestic market. Everything runs...

Read the full report →
RS rating: 85 Stage: Stage 2

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Lyka Labs Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.